It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which works by mimicking a hormone that helps control blood sugar, insulin levels, and appetite
Wonderful article, very well researched
Is Ozempic safe for people with high blood pressure
Orforglipron (Foundayo) New for 2026 The newest addition to the metabolic toolkit, this is a non-peptide oral medication recently approved by the FDA
Some patients report isolated episodes rather than continuous symptoms, suggesting adaptation occurs as the body acclimates to the medication
Retatrutide activates three receptors (GLP-1, GIP, and glucagon) compared to semaglutide's single GLP-1 target and tirzepatide's dual GLP-1/GIP mechanism